KTTA insider filings

Pasithea Therapeutics Corp. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-17. Screen KTTA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Coastlands Capital LP — 10% owner13 legs · 1,667,514 sh · $805,944——

Recent insider filings — Pasithea Therapeutics Corp.

FiledFormInsiderReported transactionsSource
2026-11-174Coastlands Capital LP — 10% ownerPurchase (P): 209,431 @ $0.50 · Purchase (P): 583,083 @ $0.50 · Purchase (P): 875,000 @ $0.47EDGAR
2026-06-224Coastlands Capital LP — 10% ownerPurchase (P): 100,000 @ $0.53EDGAR
2026-05-054Marques Tiago — Chief Executive Officer, DirectorGrant/award (A): 1,756,069 (derivative) @ $0EDGAR
2026-05-054Dumesnil Simon — DirectorGrant/award (A): 152,783 (derivative) @ $0EDGAR
2026-05-054Krishnan Kartik — Chief Medical OfficerGrant/award (A): 1,129,323 (derivative) @ $0EDGAR
2026-05-054Leahy Emer — DirectorGrant/award (A): 152,783 (derivative) @ $0EDGAR
2026-05-054Schneiderman Daniel H — Chief Financial OfficerGrant/award (A): 1,129,323 (derivative) @ $0EDGAR
2026-05-054Novak Alfred J — DirectorGrant/award (A): 152,783 (derivative) @ $0EDGAR
2026-05-054STEINMAN LAWRENCE — DirectorGrant/award (A): 152,783 (derivative) @ $0EDGAR
2025-12-014Marques Tiago — Chief Executive Officer, DirectorPurchase (P): 33,333 @ $0.75EDGAR
2025-12-014Dumesnil Simon — DirectorPurchase (P): 33,333 @ $0.75EDGAR
2025-12-014Leahy Emer — DirectorGrant/award (A): 33,333 @ $0.75EDGAR
2025-12-014Schneiderman Daniel H — Chief Financial OfficerGrant/award (A): 26,667 @ $0.75EDGAR
2025-12-014STEINMAN LAWRENCE — DirectorPurchase (P): 133,333 @ $0.75EDGAR
2025-10-274Marques Tiago — Chief Executive Officer, DirectorGrant/award (A): 493,341 (derivative) @ $0EDGAR
2025-10-274Leahy Emer — DirectorGrant/award (A): 42,913 (derivative) @ $0EDGAR
2025-10-274Dumesnil Simon — DirectorGrant/award (A): 42,913 (derivative) @ $0EDGAR
2025-10-274Schneiderman Daniel H — Chief Financial OfficerGrant/award (A): 317,266 (derivative) @ $0EDGAR
2025-10-274Novak Alfred J — DirectorGrant/award (A): 42,913 (derivative) @ $0EDGAR
2025-10-274STEINMAN LAWRENCE — DirectorGrant/award (A): 242,913 (derivative) @ $0EDGAR
2025-05-144Marques Tiago — Chief Executive Officer, DirectorSale (S): 960 @ $0.82EDGAR
2024-06-144Novak Alfred J — DirectorGrant/award (A): 750 @ $5.61 · Grant/award (A): 2,750 @ $5.62EDGAR
2024-04-054/AMarques Tiago — Chief Executive Officer, DirectorGrant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 11,669 (derivative) @ $0EDGAR
2024-04-054/ALeahy Emer — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2024-04-054/ACurrie Graeme Martin — Chief Development OfficerGrant/award (A): 5,938 (derivative) @ $0EDGAR
2024-04-054/ADumesnil Simon — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2024-04-054/ASchneiderman Daniel H — Chief Financial OfficerGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,927 (derivative) @ $0EDGAR
2024-04-054/ANovak Alfred J — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-04-054/ASTEINMAN LAWRENCE — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2024-03-014Marques Tiago — Chief Executive Officer, DirectorGrant/award (A): 15,000 (derivative) @ $0 · Grant/award (A): 11,669 (derivative) @ $0EDGAR
2024-03-014Leahy Emer — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2024-03-014Dumesnil Simon — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2024-03-014Currie Graeme Martin — Chief Development OfficerGrant/award (A): 5,938 (derivative) @ $0EDGAR
2024-03-014Schneiderman Daniel H — Chief Financial OfficerGrant/award (A): 10,000 (derivative) @ $0 · Grant/award (A): 5,927 (derivative) @ $0EDGAR
2024-03-014Novak Alfred J — DirectorGrant/award (A): 5,000 (derivative) @ $0EDGAR
2024-03-014STEINMAN LAWRENCE — DirectorGrant/award (A): 7,500 (derivative) @ $0EDGAR
2023-06-064STEINMAN LAWRENCE — DirectorPurchase (P): 30,000 @ $0.43EDGAR
2023-06-064/ASTEINMAN LAWRENCE — DirectorHoldings only — no transactions reportedEDGAR
2022-11-284Marques Tiago — Chief Executive Officer, DirectorGrant/award (A): 5,000 @ $1 · Grant/award (A): 1,000 @ $1.03 · Grant/award (A): 1,206 @ $1.02 · Grant/award (A): 2,000 @ $1.03EDGAR
2022-11-284STEINMAN LAWRENCE — DirectorGrant/award (A): 5,000 @ $0.98EDGAR
2022-11-224STEINMAN LAWRENCE — DirectorGrant/award (A): 5,000 @ $0.99EDGAR
2022-11-174Dumesnil Simon — DirectorGrant/award (A): 10,000 @ $1.07 · Grant/award (A): 40,000 @ $1.06 · Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-10-264STEINMAN LAWRENCE — DirectorGrant/award (A): 5,000 @ $1.10EDGAR
2022-10-244Novak Alfred J — DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2022-10-214Marques Tiago — Chief Executive Officer, DirectorGrant/award (A): 600 @ $1.08 · Grant/award (A): 4,400 @ $1.07EDGAR
2022-10-194Delaney David
Concord IP2 Ltd.
Elderhill Corp
Purchase (P): 1,000 @ $1.11EDGAR
2022-10-174STEINMAN LAWRENCE — DirectorGrant/award (A): 1,000 @ $1.14 · Grant/award (A): 9,000 @ $1.13EDGAR
2022-10-124Schneiderman Daniel H — Chief Financial OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2022-09-304Shahinian Eric
Camac Capital, LLC
Camac Fund, LP
Camac Partners, LLC
Purchase (P): 57,647 @ $1.19 · Purchase (P): 6,710 @ $1.16EDGAR
2022-09-064Shahinian Eric
Camac Capital, LLC
Camac Fund, LP
Camac Partners, LLC
Purchase (P): 55,646 @ $1.13 · Purchase (P): 11,507 @ $1.14 · Purchase (P): 21,748 @ $1.13EDGAR

Recent 8-K events — Pasithea Therapeutics Corp.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-168-K8.01 — Other EventsEDGAR
2026-09-098-K5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-218-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-05-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-208-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-01-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-158-K8.01 — Other EventsEDGAR
2025-12-028-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-258-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=KTTA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs